The goal of this monthly webinar series is to provide sickle cell disease providers, warriors, caregivers, and their families with tailored expertise and the opportunity to interact with experts through our live virtual Q&A sessions.
CMEs and Enduring Materials are offered.
The objectives addressed:
Know the basics of the Transcranial Doppler Ultrasound (TCD)
Know what constitutes normal and abnormal TCD
Know the ages and issues involved in obtaining a TCD
Know what the treatment plan is for those children with an abnormal TCD
Know how to proceed if the TCD is conditional or abnormal
Meet our Subject-Matter Expert | Robert J. Adams, MS. M.D.
Robert J. Adams, MS, M.D. formerly the presidential distinguished chair, regents professor of neurology, and co-director of the cerebrovascular section in the Department of Neurology at the Medical College of Georgia in Augusta, Georgia, moved to MUSC in 2007 and assumed the titles of university eminent scholar, professor of neuroscience and director of the South Carolina Center for Economic Excellence in Stroke. Dr. Adams is certified by the American Board of Psychiatry and Neurology (diplomate) and the National Board of Medical Examiners. Dr. Adams received his Bachelor of Science in electrical engineering from St. Louis University and his medical degree from the University of Arkansas for Medical Sciences. He also has an MS degree in engineering design and economic evaluation from the University of Colorado at Boulder.
Meet our Moderator | Keith Quirolo, M.D.
Dr. Quirolo has a degree in biology from San Francisco State University, a degree in nursing from the UCSF School of Nursing, he received his MD degree from Case Western Reserve School of Medicine and completed a Fellowship in Transfusion Medicine at UCSF. Dr. Quirolo practiced as an RN for approximately 10 years in pediatric oncology and intensive care in the Bay Area and during medical school at Rainbow Baby and Children’s Hospital in Cleveland Ohio. After his pediatric residency he entered private pediatric practice in Berkeley for about 10 years. He moved to the sickle cell program at the then Children’s Hospital Oakland in 1995. He served as the Director of Pediatric Sickle Cell Program at UCSF Benioff Children’s Hospital in Oakland for 20 years. Keith served on the FDA Blood Advisory Committee for two years, he initiated and directed the Clinical Apheresis Program at UCSF Benioff Children’s Hospital for 17 years. Keith has left the practice of medicine and is currently consulting for community-based organizations and other advocacy projects.